UroLift is covered by most major insurance plans, including Medicare and many private insurers, when specific clinical criteria are met. The procedure is recognized as a medically necessary treatment for benign prostatic hyperplasia (BPH), but approval almost always requires documentation that medications didn’t work first and that your prostate falls within certain size limits.
What Insurers Require for Approval
Insurance companies treat UroLift as a second-line option, meaning you need to show that BPH medications failed before the procedure will be covered. Most policies require documented failure of, inability to tolerate, or undesirable side effects from at least one category of BPH medication. The drugs insurers expect you to have tried first include alpha blockers (like tamsulosin or doxazosin) and 5-alpha reductase inhibitors (like finasteride or dutasteride), or combination therapy using both.
“Failure” doesn’t just mean the medication didn’t help. Insurers also accept documented side effects that made the drug intolerable, such as dizziness, sexual dysfunction, or fatigue. Your urologist will need to have this medication history in your chart before submitting for approval.
Prostate Size and Anatomy Limits
Every insurer sets a maximum prostate volume for UroLift coverage, though the exact number varies. Most major carriers cap it at 80 mL (or 80 grams, which is roughly equivalent for prostate tissue). Some plans, like Molina Healthcare, allow coverage up to 100 cc. The American Urological Association’s 2023 guidelines recommend UroLift for prostates between 30 and 80 grams, and most insurers follow that range closely.
Prostate anatomy matters just as much as size. A protruding or obstructive median lobe, the central portion of the prostate that can push up into the bladder, is a common reason for denial. UroLift implants are designed to pin back the lateral lobes of the prostate, and the device isn’t effective when the middle lobe is the primary source of obstruction. Your urologist can determine lobe anatomy through imaging or a cystoscopy performed before the procedure.
Full Eligibility Checklist
While exact criteria differ between insurers, most require all of the following before approving UroLift:
- Age 45 or older (some plans set the threshold at 50)
- Documented BPH symptoms such as weak urine stream, frequent nighttime urination, urgency, difficulty starting or stopping urination, or feeling that the bladder doesn’t fully empty
- Failed or intolerable medication trial with alpha blockers, 5-alpha reductase inhibitors, or both
- Prostate volume at or below 80 mL (up to 100 mL with some plans)
- No obstructive median lobe
- No active urinary tract infection or recent prostatitis within the past year
- No allergy to nickel, titanium, or stainless steel (the implants contain these metals)
If you don’t meet all of these criteria, most insurers will classify the procedure as investigational and deny coverage. Repeat UroLift procedures are also typically considered investigational and won’t be approved.
Medicare Coverage
Medicare does not have a national coverage determination specifically for UroLift, and no local coverage determinations exist either. In practice, this means Medicare processes UroLift claims on a case-by-case basis using general medical necessity guidelines rather than a specific written policy. Most Medicare beneficiaries who meet the standard clinical criteria (appropriate prostate size, no obstructive median lobe, failed medications) do receive coverage, but the lack of a formal policy means the approval process can be less predictable than with private insurers. If you have a Medicare Advantage plan, coverage follows that plan’s commercial policy rather than original Medicare rules.
Prior Authorization and Documentation
Most insurers require prior authorization before you schedule a UroLift procedure. Your urologist’s office handles the submission, but knowing what’s needed can help you avoid delays. The insurer will typically want to see records documenting your BPH symptoms, a list of medications you’ve tried and why they didn’t work, prostate volume measured by ultrasound or similar imaging, and confirmation that your prostate anatomy is appropriate (no obstructive median lobe).
The procedure is billed under two CPT codes: 52441 for the first implant and 52442 for each additional implant. Most patients receive four to six implants during a single procedure. When calling your insurance company to verify benefits, referencing these codes can help the representative pull up the correct policy and give you accurate cost-sharing information, including your copay, coinsurance, and whether the procedure is subject to your deductible.
What to Do if You’re Denied
Denials most often happen because of incomplete documentation rather than true ineligibility. If your claim is denied, start by requesting the specific reason in writing. Common fixable issues include missing records of a medication trial, no prostate volume measurement on file, or a coding error on the claim. Your urologist’s office can submit additional documentation and file an appeal. Many denials are overturned on the first appeal once the right records are attached.
If your prostate has an obstructive median lobe or exceeds the size limit for your plan, the denial is likely to stand. In those cases, your urologist can discuss alternative procedures that may be covered for your specific anatomy, such as transurethral resection or other minimally invasive options designed for larger prostates or median lobe obstruction.